Intuitive Surgical Trails Becton, Dickinson as Peer Reports Q4 Revenue of $5.3 Billion
Intuitive Surgical shares have fallen 10.7% over the past year and 11.1% year-to-date, trailing Becton, Dickinson’s 15.8% rally over the last three months. Becton, Dickinson reported Q4 revenue of $5.3 billion (+1.6% YoY) and adjusted EPS of $2.91, surpassing estimates and trading just 5.8% below its 52-week high.
1. Market Position and Size
Becton, Dickinson is valued at a $50.3 billion market cap, classifying it as a large-cap medtech leader developing and selling medical supplies, devices and interventional solutions globally.
2. Share Price Trends and Averages
BDX shares have rallied 15.8% over the past three months and 15.7% year-to-date, trading 5.8% below their Feb. 24 52-week high of $187.35 while maintaining positions above both the 50-day and 200-day moving averages.
3. Q4 Financial Results and Outlook
In Q4, Becton, Dickinson posted revenue of $5.3 billion, up 1.6% year-over-year, and delivered adjusted EPS of $2.91 versus $2.82 estimates, though management highlighted persistent macroeconomic and regulatory headwinds in China and vaccine demand.
4. Peer Underperformance by Intuitive Surgical
Intuitive Surgical shares declined 10.7% over the past 52 weeks and 11.1% year-to-date, underperforming Becton, Dickinson’s gains and underscoring divergent performance within the medical technology sector.